The unique characteristics of COVID-19 coagulopathy.
Thrombotic complications and coagulopathy frequently occur in COVID-19. However, the characteristics of COVID-19-associated coagulopathy (CAC) are distinct from those seen with bacterial sepsis-induced coagulopathy (SIC) and disseminated intravascular coagulation (DIC), with CAC usually showing increased D-dimer and fibrinogen levels but initially minimal abnormalities in prothrombin time and platelet count. Venous thromboembolism and arterial thrombosis are more frequent in CAC compared to SIC/DIC. Clinical and laboratory features of CAC overlap somewhat with a hemophagocytic syndrome, antiphospholipid syndrome, and thrombotic microangiopathy. We summarize the key characteristics of representative coagulopathies, discussing similarities and differences so as to define the unique character of CAC.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- SARS-CoV-2
- Pneumonia, Viral
- Platelet Aggregation
- Pandemics
- Inflammation Mediators
- Humans
- Emergency & Critical Care Medicine
- Coronavirus Infections
- COVID-19
- Blood Coagulation Tests
Citation
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- SARS-CoV-2
- Pneumonia, Viral
- Platelet Aggregation
- Pandemics
- Inflammation Mediators
- Humans
- Emergency & Critical Care Medicine
- Coronavirus Infections
- COVID-19
- Blood Coagulation Tests